| P2093 | author name string | Stephen J Smith | |
| | Peter D Drummond | |
| | Adrian L Lopresti | |
| | Alexandra P Metse | |
| P2860 | cites work | Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems | Q28240809 |
| | Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices | Q28306135 |
| | Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiography | Q33370458 |
| | Short- and long-term health consequences of sleep disruption | Q33739870 |
| | Subjective perception of sleep, but not its objective quality, is associated with immediate postpartum mood disturbances in healthy women | Q33770504 |
| | Development and evaluation of a measure to assess restorative sleep | Q33793991 |
| | Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. | Q34447135 |
| | Herbal medicine for insomnia: A systematic review and meta-analysis. | Q34461000 |
| | GABA mechanisms and sleep | Q34619980 |
| | The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. | Q34821415 |
| | Clinical guideline for the evaluation and management of chronic insomnia in adults. | Q34852294 |
| | Dysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16) | Q36151517 |
| | Prevalence, course, and comorbidity of insomnia and depression in young adults. | Q36519093 |
| | Validation of self-reported sleep against actigraphy | Q37234484 |
| | Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality | Q37700406 |
| | Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies | Q37837216 |
| | Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents | Q40054369 |
| | Sleep health of Australian adults in 2016: results of the 2016 Sleep Health Foundation national survey. | Q40272320 |
| | Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland | Q44180247 |
| | The use of natural products for sleep: A common practice? | Q46019458 |
| | Public health implications of sleep loss: the community burden. | Q46229405 |
| | Safranal enhances non-rapid eye movement sleep in pentobarbital-treated mice. | Q48242533 |
| | Crocin promotes non-rapid eye movement sleep in mice | Q48276316 |
| | Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive-compulsive disorder | Q48610664 |
| | The Pittsburgh Sleep Diary | Q48840728 |
| | Insomnia with Objective Short Sleep Duration and Risk of Incident Cardiovascular Disease and All-Cause Mortality: Sleep Heart Health Study. | Q52664599 |
| | Multiple tests on saffron find new adulterant materials and reveal that Ist grade saffron is rare in the market | Q57453864 |
| | Insomnia symptoms are associated with elevated C-reactive protein in young adults | Q57788853 |
| | Prescription and Nonprescription Sleep Product Use Among Older Adults in the United States | Q58554658 |
| | Immunoregulatory and anti-inflammatory properties of Crocus sativus (Saffron) and its main active constituents: A review. | Q64898342 |
| | Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples | Q73014086 |
| | Insomnia symptoms and their association with workplace productivity: cross-sectional and pre-post intervention analyses from a large multinational manufacturing company | Q88731137 |
| | The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis | Q90418756 |
| | Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis | Q92338979 |
| | The involvement of sleep in the relationship between the serotonin transporter gene-linked polymorphic region (5-HTTLPR) and depression: A systematic review | Q92634019 |
| | Efficacy of a standardised saffron extract (affron®) as an add-on to antidepressant medication for the treatment of persistent depressive symptoms in adults: A randomised, double-blind, placebo-controlled study | Q93051519 |
| | The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial | Q93378985 |
| | Effect of crocetin on quality of sleep: A randomized, double-blind, placebo-controlled, crossover study | Q93379079 |
| P921 | main subject | placebo | Q269829 |
| | placebo-controlled trial | Q108853737 |
| P577 | publication date | 2020-02-14 | |
| P1433 | published in | The Journal of Clinical Sleep Medicine | Q15766748 |
| P1476 | title | Effects of Saffron on Sleep Quality in Healthy Adults With Self-Reported Poor Sleep: A Randomized, Double-Blind, Placebo-Controlled Trial | |